Cerus Corp (CERS)
1.665
+0.03
(+2.00%)
USD |
NASDAQ |
Apr 18, 12:52
Cerus Enterprise Value: 310.65M for April 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 17, 2024 | 310.65M |
| April 16, 2024 | 319.29M |
| April 15, 2024 | 328.36M |
| April 12, 2024 | 331.98M |
| April 11, 2024 | 322.01M |
| April 10, 2024 | 323.82M |
| April 09, 2024 | 353.74M |
| April 08, 2024 | 359.18M |
| April 05, 2024 | 353.74M |
| April 04, 2024 | 357.36M |
| April 03, 2024 | 355.55M |
| April 02, 2024 | 333.80M |
| April 01, 2024 | 341.05M |
| March 28, 2024 | 357.36M |
| March 27, 2024 | 339.23M |
| March 26, 2024 | 330.17M |
| March 25, 2024 | 331.98M |
| March 22, 2024 | 351.92M |
| March 21, 2024 | 368.24M |
| March 20, 2024 | 371.86M |
| March 19, 2024 | 384.55M |
| March 18, 2024 | 351.92M |
| March 15, 2024 | 360.99M |
| March 14, 2024 | 373.68M |
| March 13, 2024 | 382.74M |
| Date | Value |
|---|---|
| March 12, 2024 | 402.68M |
| March 11, 2024 | 411.75M |
| March 08, 2024 | 424.44M |
| March 07, 2024 | 446.19M |
| March 06, 2024 | 453.44M |
| March 05, 2024 | 375.49M |
| March 04, 2024 | 399.06M |
| March 01, 2024 | 409.93M |
| February 29, 2024 | 409.93M |
| February 28, 2024 | 413.56M |
| February 27, 2024 | 428.06M |
| February 26, 2024 | 415.37M |
| February 23, 2024 | 415.37M |
| February 22, 2024 | 417.19M |
| February 21, 2024 | 420.81M |
| February 20, 2024 | 433.50M |
| February 16, 2024 | 442.57M |
| February 15, 2024 | 448.00M |
| February 14, 2024 | 436.22M |
| February 13, 2024 | 408.12M |
| February 12, 2024 | 444.38M |
| February 09, 2024 | 442.57M |
| February 08, 2024 | 431.69M |
| February 07, 2024 | 413.48M |
| February 06, 2024 | 418.92M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
226.91M
Minimum
Oct 19 2023
1.340B
Maximum
Dec 22 2020
730.73M
Average
749.84M
Median
Enterprise Value Benchmarks
| AVITA Medical Inc | 192.14M |
| Elutia Inc | 78.19M |
| Perspective Therapeutics Inc | 831.78M |
| Xtant Medical Holdings Inc | 118.22M |
| Asensus Surgical Inc | 49.65M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.328M |
| Revenue (Quarterly) | 46.77M |
| Total Expenses (Quarterly) | 45.79M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 55.51% |
| Profit Margin (Quarterly) | -2.84% |
| Earnings Yield | -12.61% |
| Normalized Earnings Yield | -11.46 |